Evidence map›Paper›PMID 27466070›Full record

ReviewJournal of addiction medicine

An Argument for Change in Tobacco Treatment Options Guided by the ASAM Criteria for Patient Placement.

Jill M Williams, Marc L Steinberg, Alexandra N Kenefake, Michael V Burke

Abstract readReview
In one paragraph

Review in Journal of addiction medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Proactive Tobacco Treatment in a Behavioral Health Home.Community mental health journal · 2020
    Trial
  2. Trial
  3. Article
  4. Article
  5. Integration of Tobacco Treatment Services into Cancer Care at Stanford.International journal of environmental research and public health · 2020
    Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jill M WilliamsRutgers Robert Wood Johnson Medical School (JMW, MLS, ANK), New Brunswick, NJ; and Mayo Medical Center, Rochester, MN (MVB).
Marc L Steinberg
Alexandra N Kenefake
Michael V Burke

Funding

Tailored NRT Integrated with Smartphone Behavioral SupportR44CA199920 · NCI · CHRONO THERAPEUTICS, INC. · PI LEVY, ALAN JOEL · 2015 to 2017
$2.2M
Persistence-Targeted Smoking CessationR34DA030652 · NIDA · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI STEINBERG, MARC L · 2011 to 2013
$720k
NCI NIH HHS R44 CA199920NIDA NIH HHS R34 DA030652
6 · The paper itself

Abstract

Tobacco use is a major threat to public health in the United States, and the number one cause of preventable death. Although most smokers try to quit unaided, robust data indicate that pairing behavioral support to US Food Drug Administration-approved cessation medications significantly increase cessation rates. Those who do receive assistance in quitting usually receive very low intensity treatment, regardless of the severity of their dependence or their medical and environmental circumstances. This is in stark contrast to how other substance use disorders are treated, where there are varying levels of care depending on addiction severity and biopsychosocial circumstances. The American Society of Addiction Medicine (ASAM) developed a formal algorithm for assessing substance use disorders and determining the optimal level of care. The ASAM Patient Placement Criteria are regularly used to determine the appropriate level of care for all substance use disorders except tobacco. This paper will review key aspects of the ASAM dimensions of care and placement levels, with emphasis on how they apply to tobacco use and present case examples of typical smokers who would benefit from a higher intensity of tobacco dependence treatment. We also present current barriers to reimbursing healthcare providers for these services. We conclude with a commentary and discussion regarding recommendations for improvements in tobacco dependence treatment care.

Indexed as

HumansPractice Guidelines as TopicSmokingSmoking CessationSocieties, MedicalSubstance-Related Disorders

Identifiers

PMID27466070
PMCPMC5049967

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.